The Tashkent Interdistrict Economic Court cancel the permit of Quramax Medikal to conduct pharmaceutical activities in Uzbekistan, issued by the Pharmaceutical Industry Development Agency on December 10, 2019, the press service of the Supreme Court said.
The court ruled unusable drugs shall be withdrawn from circulation and destroy them.
The Supreme Court added that the ruling could be appealed, otherwise it will take effect in 10 days.
In addition, the court issued a private ruling on violation of the law in relation to the actions or inaction of the authorized body and officials in this economic case and sending it to the Tashkent prosecutor's office. This ruling may also be appealed.
The Indian authorities have suspended the pharmacological license of Marion Biotech.
The company is currently under investigation for its Doc-1 Max cough syrup. An Uttar Pradesh state official said the stoppage order was issued on January 10 when the company failed to provide documentation for the drug.
Doc-1 Max was produced only for export to Uzbekistan, the source of the publication emphasized. Over the past 45 days of production, Marion Biotech has shipped nearly 100,000 packs of the drug.
To date, at least 20 deaths have been officially confirmed as a result of the use of this syrup.
The new Minister of Health, Amrillo Inoyatov, in his letter to pharmacies in early January, instructed to suspend the sale of all medicines imported by Quramax in 2022.
